The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.116.2.169

Use-rates for 9 tranquilizing and 3 stimulant drugs or drug-combinations were recorded in a state hospital population over a 4 year period, ending December 31, 1958. Data were plotted graphically, and userates were observed in descending order for chlorpromazine, promazine, reserpine, proclorpromazine, meprobamate, triflupromazine, mepazine, mepazine plus chlorpromazine, reserpine plus chlorpromazine, benzedrine, methylphenidate, and iproniazid.

By the end of the observation period, 61% of the total hospital population, (21% of the male, and 40% of the female populations) were receiving one or more of the drugs. Of the total, male, and female populations on drugs, 34%, 11%, and 23% respectively were receiving chlorpromazine.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.